- Home
- MPTI vs TLSA Comparison
MPTI vs TLSA Comparison
Compare MPTI & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MPTI
- TLSA
- Stock Information
- Founded
- MPTI 1965
- TLSA 2013
- Country
- MPTI United States
- TLSA United Kingdom
- Employees
- MPTI N/A
- TLSA N/A
- Industry
- MPTI
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- MPTI
- TLSA Health Care
- Exchange
- MPTI Nasdaq
- TLSA Nasdaq
- Market Cap
- MPTI 117.1M
- TLSA 87.8M
- IPO Year
- MPTI N/A
- TLSA 2000
- Fundamental
- Price
- MPTI $50.49
- TLSA $0.88
- Analyst Decision
- MPTI
- TLSA
- Analyst Count
- MPTI 0
- TLSA 0
- Target Price
- MPTI N/A
- TLSA N/A
- AVG Volume (30 Days)
- MPTI 35.3K
- TLSA 120.4K
- Earning Date
- MPTI 11-07-2024
- TLSA 05-10-2024
- Dividend Yield
- MPTI N/A
- TLSA N/A
- EPS Growth
- MPTI 87.47
- TLSA N/A
- EPS
- MPTI 1.76
- TLSA N/A
- Revenue
- MPTI $44,654,000.00
- TLSA N/A
- Revenue This Year
- MPTI $18.43
- TLSA N/A
- Revenue Next Year
- MPTI $8.16
- TLSA N/A
- P/E Ratio
- MPTI $28.53
- TLSA N/A
- Revenue Growth
- MPTI 22.02
- TLSA N/A
- 52 Week Low
- MPTI $20.90
- TLSA $0.41
- 52 Week High
- MPTI $53.04
- TLSA $1.74
- Technical
- Relative Strength Index (RSI)
- MPTI 68.80
- TLSA 41.97
- Support Level
- MPTI $45.55
- TLSA $0.83
- Resistance Level
- MPTI $53.04
- TLSA $0.92
- Average True Range (ATR)
- MPTI 3.18
- TLSA 0.06
- MACD
- MPTI 0.18
- TLSA -0.01
- Stochastic Oscillator
- MPTI 76.41
- TLSA 19.19
About MPTI M-tron Industries Inc.
M-Tron Industries Inc is a diversified holding company with subsidiaries engaged in designing, manufacturing, and marketing high-engineered, high-reliability frequency and spectrum control products used to control the frequency or timing of signals in electronic circuits in various applications. The serving markets of the company are aerospace and defense, space, and avionics. The company offers products such as microwave and millimeter wave filters; cavity, crystal, ceramic, lumped element, and switched filters; crystal resonators, integrated microwave assemblies, and solid-state power amplifier products.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.